skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Hepatorenal syndrome: pathophysiology, diagnosis, and management

BMJ (Online), 2020-09, Vol.370, p.m2687-m2687 [Peer Reviewed Journal]

ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m2687

Full text available

Citations Cited by
  • Title:
    Hepatorenal syndrome: pathophysiology, diagnosis, and management
  • Author: Simonetto, Douglas A ; Gines, Pere ; Kamath, Patrick S
  • Is Part Of: BMJ (Online), 2020-09, Vol.370, p.m2687-m2687
  • Description: ABSTRACT Hepatorenal syndrome (HRS), the extreme manifestation of renal impairment in patients with cirrhosis, is characterized by reduction in renal blood flow and glomerular filtration rate. Hepatorenal syndrome is diagnosed when kidney function is reduced but evidence of intrinsic kidney disease, such as hematuria, proteinuria, or abnormal kidney ultrasonography, is absent. Unlike other causes of acute kidney injury (AKI), hepatorenal syndrome results from functional changes in the renal circulation and is potentially reversible with liver transplantation or vasoconstrictor drugs. Two forms of hepatorenal syndrome are recognized depending on the acuity and progression of kidney injury. The first represents an acute impairment of kidney function, HRS-AKI, whereas the second represents a more chronic kidney dysfunction, HRS-CKD (chronic kidney disease). In this review, we provide critical insight into the definition, pathophysiology, diagnosis, and management of hepatorenal syndrome.
  • Language: English
  • Identifier: ISSN: 1756-1833
    EISSN: 1756-1833
    DOI: 10.1136/bmj.m2687
  • Source: ProQuest Central

Searching Remote Databases, Please Wait